
Hong Kong woman opens up about life after moment her heart stopped beating
She was a 19-year-old student at the time and had suffered a fulminant myocarditis attack, a rare and severe illness that can cause heart failure.
Cheung, now a 30-year-old art teacher, has since developed the ability to cope with the uncertainties surrounding her condition, thanks to the special care of the medical team at Queen Mary Hospital's intensive care unit (ICU).
'I have experienced [near death], I don't think there's anything [my family and I] can't deal with,' she said.
Cheung and her doctor spoke to the media on Monday as part of the hospital's work with the Shaw Foundation to offer in-person and online activities to educate the public about intensive care treatments and patients' experiences.
Last year, lawmakers passed a legislative amendment that allows terminally ill patients to reject certain treatments, such as undergoing cardiopulmonary resuscitation (CPR), as the end of their life nears.
Simon Sin Wai-ching, the critical care unit doctor at Queen Mary Hospital who treated Cheung, said he hoped more of the public, especially young people, would give more thought to what first aid options they were willing to undergo.
'How do patients feel before entering the ICU? How do they feel during intubation? If we can set up a platform for them to share such stories, it's much more effective than having doctors and residents guess what those procedures feel like,' he said.
He noted that less than 20 per cent of patients die in ICUs, where hospitals' best resources are available.
Speaking about his time treating Cheung, the doctor said her heart had suddenly skipped a few beats when she began suffering the fulminant myocarditis attack.
Sin said the hospital where Cheung was initially admitted had lacked an extracorporeal membrane oxygenation machine (ECMO), which acts as an artificial heart and lung.
An ECMO and a team of specialists had to be brought over from Queen Mary Hospital to keep her alive, he added.
The doctor recalled that the team was still travelling to the other hospital by taxi when they learned that Cheung's heart had completely stopped.
At the time of Cheung's fulminant myocarditis attack, each procedure using an ECMO cost more than HK$1 million. Most patients cannot survive undergoing CPR for more than 20 minutes.
'But the whole team was already in the taxi, and there was no place for a U-turn, so we sped ahead,' Sin said, noting an experienced ICU doctor who was jogging nearby had rushed to the hospital to perform CPR on Cheung.
Sixty-three minutes later, the specialist team were prepared for the operation and managed to get Cheung's heart beating again.
Sin recounted Cheung's miraculous survival in his book, When Suffering Becomes Life , which shares the post-ICU stories of his former patients.
Surviving also marked the start of a life of recovery for Cheung.
'I had to relearn writing and walking, but I picked up those skills again very quickly,' she said.
Her father, Cheung Wing-hung, said: 'When I first heard Olivia was saved, I worried about taking care of her. Would she need support to use the toilet [after hospitalisation]?'
While Olivia Cheung gradually recovered from her near-death experience, it continued to have an impact on her life eight years later, when she woke up one night having wet the bed and with a bleeding tongue.
In a check-up, doctors found she had epilepsy as her brain lacked oxygen when her heart stopped.
'Now I cannot drive a car. The medicine for epilepsy also made me too tired to work during the first two weeks I was on it,' she said.
But Cheung said that, in spite of her experiences, she remained positive and felt her problems were 'minor ones' compared with what others had gone through.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


The Star
4 days ago
- The Star
2nd measles death reported in Israel amid surging cases
JERUSALEM, Aug. 16 (Xinhua) -- An 18-month-old Israeli boy died of measles on Saturday at Jerusalem's Shaare Zedek Medical Center, marking the second fatality in the country's current measles outbreak, Israel's Health Ministry said in a statement. The toddler was unvaccinated, it noted. The first death, a two-year-old Israeli boy also unvaccinated, took place on Wednesday at Jerusalem's Hadassah Medical Center. Since the outbreak began in early April, 526 measles cases have been confirmed, including 209 active infections, the ministry said, noting that there are 19 hospitalized patients under age six, including a one-year-old girl on ECMO support. The ministry urged parents to ensure that their children are vaccinated according to the national schedule, which includes one dose at 12 months of age and a second one in the first grade. Measles is a highly contagious viral illness marked by fever, nausea, a runny nose, and a rash. In some cases, it can lead to severe and life-threatening complications.


The Sun
09-08-2025
- The Sun
HK-listed IVD Medical Invests HK$149M in Ethereum through HashKey Exchange
HONG KONG SAR - Media OutReach Newswire - 9 August 2025 - HashKey Exchange, Hong Kong's largest * licensed virtual asset trading platform, has entered into a strategic partnership with IVD Medical Holdings Limited ( a publicly listed company on the Hong Kong Stock Exchange. The two parties will collaborate to advance enterprise-level digital asset adoption and explore new models for integrating blockchain with industrial capital. IVD Medical has made a pioneering move with a HK$149 million Ethereum purchase via HashKey Exchange. With access to trading and liquidity services provided by HashKey Exchange, IVD Medical is poised to become a pioneering 'Ethereum treasury' among HK-listed companies. This partnership also marks a further step by HashKey Exchange in advancing the compliant adoption and integration of digital assets within traditional industries and Hong Kong's capital markets. Key areas of collaboration include: Block Trade Execution: Access to highly efficient and cost-effective ETH execution via HashKey OTC. Liquidity Provision: Support for large-scale transactions through HashKey Exchange's global liquidity network. Asset Optimization Initiatives: Explore yield-enhancement opportunities, including ETH staking, restaking, and DeFi yield strategies, in collaboration with HashKey Cloud, the Web3 infrastructure arm of HashKey Group. Randall Chan, VP of HashKey Exchange, commented: ' IVD Medical's forward-looking move into digital assets demonstrates how traditional industries are embracing innovation to drive growth. HashKey Exchange remains committed to the highest standards of compliance, security, and transparency, and we look forward to supporting IVD Medical in building its Ethereum treasury and exploring the tokenization of healthcare assets. Together, we aim to bridge the digital and real economies and contribute to Hong Kong's position as a global hub for financial innovation.' Gary Deng, Chief Strategy Officer of IVD Medical, added: 'We are delighted to partner with HashKey Exchange. The digital economy is the engine of future growth, and traditional industries must actively integrate to stay ahead in this new wave of technological transformation. Through this collaboration, IVD Medical aims to establish itself as a leading Ethereum Treasury player, strengthen its resilience against market volatility, and deliver long-term value to shareholders.'


The Star
04-08-2025
- The Star
Love king crab but worried about allergies? Hong Kong researchers have solution
King crab is a favourite of Hong Kong seafood lovers, as long as they do not have a reaction to the delicacy, which was among six types of shellfish found to contain eight newly identified allergens. A study led by Chinese University of Hong Kong academics looked at six types of crabs popular with local diners and found 11 allergens, including eight identified for the first time. Revealing their findings, the researchers said that a more precise diagnosis would allow patients to consume crabs to which they were not allergic. 'Crabs are one of the most important types of shellfish that cause allergic reactions,' said Leung Ting-fan, a paediatrics professor at the university. Crabs are the second largest cause of food allergy among Hong Kong pupils aged six to 11 after shrimp, affecting around 0.2 per cent of them, according to research published in 2020. Crabs are a delicacy in Hong Kong, especially the most expensive king crabs, which can cost at least HK$1,800 for one weighing 2.5kg. The best season for king crabs is considered winter, with ones sourced from the cold waters of Alaska, Russia and Hokkaido in Japan highly prized. In the latest study, researchers collected blood samples from 64 subjects who have reported an allergy to crabs. The samples were tested for allergic reactivity with different substances extracted from five locally procured edible crabs – snow crab, flower crab, hairy crab, crucifix crab and green mud crab. The king crab was also included. King crabs are not considered 'true crabs'. They are closely related to hermit crabs and are considered 'false crabs' due to their evolutionary lineage and anatomical features. Professor Chu Ka-hou, a professor emeritus at the university's life sciences school, said the king crab evolved from different ancestors. 'Therefore, its biological protein structure is different from that of true crabs,' Chu said. A key difference was that king crabs only had eight legs, but others had 10, he said. Eleven allergens were found across the six types of shellfish, with eight being newly identified. The team also found that different crabs displayed different combinations of allergens. The findings were published in a recent edition of the peer-reviewed journal Allergy and presented at two international academic conferences. 'If we can understand different [allergy] patterns of different patients, we can help them hopefully avoid crabs that they are allergic to, while they can enjoy other crabs that don't have such allergens,' Leung said. While different crabs contain various sets of allergens, shellfish parts may also play a role. Mercy Chow Man-ching, 17, has been allergic to various types of fish, but not crabs or shrimp, since the age of one. However, two months ago, about 10 minutes after eating some raw crab and crab roe in South Korea, Chow displayed acute allergic symptoms. 'I felt my throat swelling and I was dizzy. My lips were swelling, too,' she said. Chow took anti-allergy pills and saw a doctor back in Hong Kong. A check found her blood had reacted to haemocyanin, an allergen identified in the study that is commonly found in crab roe. Doctors said eating crab roe could have been a reason for her acute symptoms, pending further investigation. The research findings would also contribute to the development of differentiated allergen reagents, Leung said. Currently, most reagents only target allergens in snow crabs. 'Current reagents may not be as effective in testing allergens in other crabs, leading to 'fake negatives',' he said. The study also revealed a king crab-specific allergen, malate dehydrogenase. While the substance could be found across the six shellfish surveyed and even in the human body, only that extracted from king crabs would lead to an allergy. 'We have yet to identify why it has such a large difference, but we can tell this reactivity is specific [to king crab],' said Dr Christine Wai Yee-yan, a research assistant professor of paediatrics at the university. -- SOUTH CHINA MORNING POST